Abstract
Research in the pathogenesis of inflammatory bowel disease (IBD) has dramatically broadened our understanding of these complex disorders. These clinical manifestations result from a dysregulated immune response in the presence of luminal bacteria. Recent identification of mutations in the NOD2 gene, a protein involved in the sensing of bacteria, offers genetic support for the model of perturbed host-microbial interactions in Crohn’s disease. Several immunologic pathways have been identified that play a role in maintaining gut immune homeostasis. Abnormal expression of proinflammatory, deleterious cytokines such as tumor necrosis factor-’a and interferon-γ results in direct and indirect tissue damage. The search for specific causative microbial agents in IBD continues to be intense. This paper describes the advances in our understanding of IBD pathogenesis, with an emphasis on how this information is translated into patient care. The next stage of research will take advantage of such molecular biologic techniques to identify new pathogenetic mechanisms and targets for therapy tailored to individual patients.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References and Recommended Reading Papers of particular interest, published recently, have been highlighted as: Of importance Of major importance
Watts DA, Satsangi J: The genetic jigsaw of inflammatory bowel disease. Gut 2002, 50:31–36. Well-written review of genetic research in IBD.
Hugot JP, Chamaillard M, Zouali H, et al.: Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 2001, 411:599–603. This article describes the association of NOD2 mutations with Crohn’s disease.
Ogura Y, Bonen DK, Inohara N, et al.: A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 2001, 411:603–606.
Abreu MT, Taylor KD, Lin YC, et al.: Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn’s disease. Gastroenterology 2002, 123:679–688.
Abreu MT, Arnold ET, Thomas LS, et al.: TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J Biol Chem 2002, 277:20431–20437.
Rescigno M, Urbano M, Valzasina B, et al.: Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nature Immunol 2001, 2:361–367.
Monteleone I, Vavassori P, Biancone L, et al.: Immunoregulation in the gut: success and failures in human disease. Gut 2002, 50:60–64. An up-to-date review of immunoregulation in the intestine.
Spencer DM, Veldman GM, Banerjee S, et al.: Distinct inflammatory mechanisms mediate early versus late colitis in mice. Gastroenterology 2002, 122:94–105.
Taylor KD, Plevy SE, Yang H, et al.: ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn’s disease. Gastroenterology 2001, 120:1347–1355.
Hooper LV, Wong MH, Thelin A, et al.: Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001, 291:881–884. These authors bred mice under sterile conditions and reconstituted them with Bacteroides thetaiotaomicron, a normal commensal in both mice and humans.
Rath HC, Schultz M, Freitag R, et al.: Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun 2001, 69:2277–2285. A continuation of the pioneering work of these investigators in understanding host-microbial interactions.
D’Haens GR, Geboes K, Peeters M, et al.: Early lesions of recurrent Crohn’s disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 1998, 114:262–267. This study provides a rare glimpse into the natural history of Crohn’s disease lesions.
Gionchetti P, Rizzello F, Venturi A, et al.: Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000, 119:305–309.
Swidsinski A, Ladhoff A, Pernthaler A, et al.: Mucosal flora in inflammatory bowel disease. Gastroenterology 2002, 122:44–54.
Sutton CL, Kim J, Yamane A, et al.: Identification of a novel bacterial sequence associated with Crohn’s disease. Gastroenterology 2000, 119:23–31.
Hommes D, van den Blink B, Plasse T, et al.: Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn’s disease. Gastroenterology 2002, 122:7–14.
Papadakis KA, Prehn J, Moreno ST, et al.: CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn’s disease. Gastroenterology 2001, 121:246–254.
Steidler L, Hans W, Schotte L, et al.: Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000, 289:1352–1355.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Abreu, M.T. The pathogenesis of inflammatory bowel disease: Translational implications for clinicians. Curr Gastroenterol Rep 4, 481–489 (2002). https://doi.org/10.1007/s11894-002-0024-0
Issue Date:
DOI: https://doi.org/10.1007/s11894-002-0024-0